PUBLICATIONS & PRESENTATIONS
- Anti-inflammatory mechanisms of anti-sdc2 mab vb-001 contributing to neuroprotection after ischemic stroke. Federico Corti, J. Zhang, P. Perrotta, E. Ristori, C.A. Hernandez, J.W. Berman, K. Zsebo, M. Simons
- The role of vascular permeability in outcome after ischemic stroke. M. Simons
- Delayed Therapy with Humanized Anti-SDC2 MAB prevents formation of vasogenic edema and promotes Neuroprotection in non-human primates with ischemic stroke. Federico Corti, M. Weed, E. Nisbett, V. Chaseau, M. Lawrence, E. Ristori, J. Zhan, Z.W. Zhuang, D.A. Cheresh, K. Zsebo, M. Simons
- Anti-Syndecan-2 Human Monoclonal Antibody for treatment of stroke-associated edema. Federico Corti, E. Ristori, J. Zhang, Z.W. Zhuang, D.A. Cheresh, K. Zsebo, H. Duckers, M. Simons
- Anti-Syndecan 2 Antibody Treatment Reduces Edema Formation and Inflammation of Murine Laser-Induced CNV. Corti F, et. Al., Transl Vis Sci Technol. 2025
- Syndecan-2 selectively regulates VEGF-induced vascular permeability F. Corti, E. Ristori, F. Rivera-Molina, D. Toomre, J. Zhang, J. Mihailovic, Z. W. Zhuang & M. Simons 2022
- Targeting VEGF-induced vascular permeability Mark Richards and Lena Claesson-Welsh. Nature and Cardiovascular Research, 2021
- N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA165-dependent neovascularization Federico Corti, Yingdi Wang, John M Rhodes, Deepak Atri, Stephanie Archer-Hartmann , Jiasheng Zhang , Zhen W Zhuang, Dongying Chen, Tianyun Wang, Zhirui Wang, Parastoo Azadi, Michael Simons 2019
- The Janus Face of VEGF in Stroke Samuel J Geiseler, Cecilie Morland 2018
- Vascular endothelial growth factor: a neurovascular target in neurological diseases Christian Lange, Erik Storkebaum, Carmen Ruiz de Almodóvar, Mieke Dewerchin, Peter Carmeliet 2016